ATE199730T1
Pulmonary surfactant protein and related polypeptide.
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 5 January 2009, 17.7 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
71 members in 15 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 14120088 | United States of America | A | |
| 29320189 | United States of America | A |
Members71
| Document | Office | Kind | |
|---|---|---|---|
| WO8906657A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3960089A | Australia | A | |
| DK439089A | Denmark | A | |
| DK439089D0 | Denmark | D0 | |
| FI894187A0 | Finland | A0 | |
| NO893572D0 | Norway | D0 | |
| NO893572L | Norway | L | |
| EP0350506A1 | European Patent Office (EPO) | A1 | |
| JPH02502917A | Japan | A | |
| EP0350506A4 | European Patent Office (EPO) | A4 | |
| AU629233B2 | Australia | B2 | |
| US5164369A | United States of America | A | |
| IE921897A1 | Ireland | A1 | |
| CA2111342A1 | Canada | A1 | |
| WO9222315A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2177792A | Australia | A | |
| US5260273A | United States of America | A | |
| EP0590006A1 | European Patent Office (EPO) | A1 | |
| EP0593094A2 | European Patent Office (EPO) | A2 | |
| EP0590006A4 | European Patent Office (EPO) | A4 | |
| JPH06508619A | Japan | A | |
| EP0593094A3 | European Patent Office (EPO) | A3 | |
| US5407914A | United States of America | A | |
| NO177309B | Norway | B | |
| NO177309C | Norway | C | |
| AU666857B2 | Australia | B2 | |
| US5789381A | United States of America | A | |
| FI102180B | Finland | B | |
| FI102180B1 | Finland | B1 | |
| CA2288375A1 | Canada | A1 | |
| WO9849191A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6136998A | Australia | A | |
| JPH10316587A | Japan | A | |
| JPH11262389A | Japan | A | |
| US6013619A | United States of America | A | |
| JP3009690B2 | Japan | B2 | |
| EP1005485A1 | European Patent Office (EPO) | A1 | |
| BR9809321A | Brazil | A | |
| CA1341070C | Canada | C | |
| EP0350506B1 | European Patent Office (EPO) | B1 | |
| AT196298T | Austria | T | |
| ATE196298T1 | Austria | T1 | |
| DE68929248D1 | Germany | D1 | |
| DE68929248T2 | Germany | T2 | |
| EP0593094B1 | European Patent Office (EPO) | B1 | |
| AT199730T | Austria | T | |
| ATE199730T1This record | Austria | T1 | |
| DE68929287D1 | Germany | D1 | |
| AU734991B2 | Australia | B2 | |
| DE68929287T2 | Germany | T2 | |
| NZ337619A | New Zealand | A | |
| EP0590006B1 | European Patent Office (EPO) | B1 | |
| CA2288375C | Canada | C | |
| AT223436T | Austria | T | |
| ATE223436T1 | Austria | T1 | |
| DE69232760D1 | Germany | D1 | |
| DK0590006T3 | Denmark | T3 | |
| DE69232760T2 | Germany | T2 | |
| ES2182821T3 | Spain | T3 | |
| US2003099696A1 | United States of America | A1 | |
| US6613734B2 | United States of America | B2 | |
| JP3459248B2 | Japan | B2 | |
| DK174818B1 | Denmark | B1 | |
| EP1005485A4 | European Patent Office (EPO) | A4 | |
| IE20040101A1 | Ireland | A1 | |
| JP2004250459A | Japan | A | |
| NZ511640A | New Zealand | A | |
| EP1005485B1 | European Patent Office (EPO) | B1 | |
| AT397012T | Austria | T | |
| ATE397012T1 | Austria | T1 | |
| DE69839558D1 | Germany | D1 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Cancelled due to lapse of timeLapsedEELA | EELA | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 93119102
Titles2
- German
- OBERFLÄCHENAKTIVES LUNGENPROTEIN UND VERWANDTE POLYPEPTIDE
- English
- SURFACE-ACTIVE LUNG PROTEIN AND RELATED POLYPEPTIDES
Classification
- CPC, 4
- C07K14/785
- A61K38/00
- A61P11/00
- A61P11/04
- IPC, 12
- C12N15 09
- A61K31 00
- A61K38 00
- A61P11 00
- C07K7 06
- C07K7 08
- C07K14 00
- C07K14 435
- C07K14 785
- C12N5 10
- C12P21 02
- C12R1 91